Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Valmori

Showing results (41-50 of 49) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 49 results.
Cancer Research|September 2, 2000
Naturally occurring human lymphocyte antigen-A2 restricted CD8+ T-cell response to the cancer testis antigen NY-ESO-1 in melanoma patientsD Valmori, V Dutoit, D Liénard, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 1, 1997
Cytolytic T lymphocyte recognition of the immunodominant HLA-A*0201-restricted Melan-A/MART-1 antigenic peptide in melanomaP Romero, N Gervois, J Schneider, et al.
International Immunology|December 11, 1999
Optimal activation of tumor-reactive T cells by selected antigenic peptide analoguesD Valmori, J F Fonteneau, S Valitutti, et al.
Parasite Immunology|September 30, 2000
HLA-A*0201 restricted CD8+ T-lymphocyte responses to malaria: identification of new Plasmodium falciparum epitopes by IFN-gamma ELISPOTJ M González, K Peter, F Esposito, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 20, 2000
Efficient simultaneous presentation of NY-ESO-1/LAGE-1 primary and nonprimary open reading frame-derived CTL epitopes in melanomaD Rimoldi, V Rubio-Godoy, V Dutoit, et al.
Vaccine|March 1, 1997
Potent immunogenic short linear peptide constructs composed of B cell epitopes and Pan DR T helper epitopes (PADRE) for antibody responses in vivoM F del Guercio, J Alexander, R T Kubo, et al.
Cancer Research|August 2, 2001
Heterogeneous T-cell response to MAGE-A10(254-262): high avidity-specific cytolytic T lymphocytes show superior antitumor activityV Dutoit, V Rubio-Godoy, P Y Dietrich, et al.
European Journal of Immunology|November 28, 2000
Generation and characterization of malaria-specific human CD8(+) lymphocyte clones: effect of natural polymorphism on T cell recognition and endogenous cognate antigen presentationby liver cellsA Bonelo, D Valmori, F Triponez, et al.
The Journal of Experimental Medicine|June 8, 1999
BAFF, a novel ligand of the tumor necrosis factor family, stimulates B cell growthP Schneider, F MacKay, V Steiner, et al.
Pageof 5

Showing results (41-50 of 49) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 49 results.
Cancer Research|September 2, 2000
Naturally occurring human lymphocyte antigen-A2 restricted CD8+ T-cell response to the cancer testis antigen NY-ESO-1 in melanoma patientsD Valmori, V Dutoit, D Liénard, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 1, 1997
Cytolytic T lymphocyte recognition of the immunodominant HLA-A*0201-restricted Melan-A/MART-1 antigenic peptide in melanomaP Romero, N Gervois, J Schneider, et al.
International Immunology|December 11, 1999
Optimal activation of tumor-reactive T cells by selected antigenic peptide analoguesD Valmori, J F Fonteneau, S Valitutti, et al.
Parasite Immunology|September 30, 2000
HLA-A*0201 restricted CD8+ T-lymphocyte responses to malaria: identification of new Plasmodium falciparum epitopes by IFN-gamma ELISPOTJ M González, K Peter, F Esposito, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 20, 2000
Efficient simultaneous presentation of NY-ESO-1/LAGE-1 primary and nonprimary open reading frame-derived CTL epitopes in melanomaD Rimoldi, V Rubio-Godoy, V Dutoit, et al.
Vaccine|March 1, 1997
Potent immunogenic short linear peptide constructs composed of B cell epitopes and Pan DR T helper epitopes (PADRE) for antibody responses in vivoM F del Guercio, J Alexander, R T Kubo, et al.
Cancer Research|August 2, 2001
Heterogeneous T-cell response to MAGE-A10(254-262): high avidity-specific cytolytic T lymphocytes show superior antitumor activityV Dutoit, V Rubio-Godoy, P Y Dietrich, et al.
European Journal of Immunology|November 28, 2000
Generation and characterization of malaria-specific human CD8(+) lymphocyte clones: effect of natural polymorphism on T cell recognition and endogenous cognate antigen presentationby liver cellsA Bonelo, D Valmori, F Triponez, et al.
The Journal of Experimental Medicine|June 8, 1999
BAFF, a novel ligand of the tumor necrosis factor family, stimulates B cell growthP Schneider, F MacKay, V Steiner, et al.
Pageof 5